Melanoma: Translational Research and Emerging Therapies

by Sanjiv S. Agarwala (Editor), Vernon K. Sondak (Editor)

Overview

Assembling, reviewing, and synthesizing state-of-the-art information on translational research and therapies of melanoma into one convenient source, Melanoma: Translational Research and Emerging Therapies provides clinicians and researchers the necessary context and perspective to intergrate and effectively deploy cutting-edge therapies into daily practice.

This source:

• synthesizes the scientific principles, clinical trial results, and clinical implications of emerging and translational melanoma therapies



• covers the entire range of translational research and therapies, including pathogenesis, progression pathways, immunotherapy, gene therapy, adjuvant therapy, surgical staging, and metastatic disease



• provides context and perspective to enable the clinician to select and use new therapies effectively and knowledgeably

Product Details

ISBN-13:	9780849390180
Publisher:	Taylor & Francis
Publication date:	08/08/2008
Series:	Translational Medicine Series , #8
Pages:	236
Product dimensions:	6.20(w) x 9.10(h) x 0.80(d)

About the Author

SANJIV S. AGARWALA, M.D. is Chief of Medical Oncology and Hematology, Saint Luke’s Cancer Center, Bethlehem, Pennsylvania, USA. Dr. Agarwala is an internationally recognized investigator in the field of melanoma and immunotherapy and has led numerous clinical trials of immunotherapy and targeted therapy in melanoma. He has authored or contributed to more than 130 publications and has served on the editorial boards of several journals including the Journal of Clinical Oncology and American Journal of Oncology Review. Dr. Agarwala is also a member of the Melanoma Core Committee of the Eastern Cooperative Oncology Group.

VERNON K. SONDAK, M.D. is Chief of the Division of Cutaneous Oncology, H. Lee Moffitt Cancer Center, Tampa, Florida, USA. Dr. Sondak is an internationally renowned surgical oncologist specializing in melanoma and other cutaneous malignancies, and has led clinical trials in surgical management and adjuvant vaccine therapy in melanoma. He is the Chair of the Melanoma Committee of the Southwest Oncology Group, and has authored or coauthored more than 170 peer-reviewed publications and invited review articles, and has edited three previous textbooks. He has served on the editorial boards of several journals, including the Annals of Surgical Oncology and the Journal of Clinical Oncology, and was Section Editor for Melanoma for Cancer for seven years.

Table of Contents

1. UV radiation in melanoma development and pathogenesis. 2. Overview of molecular pathways in melanoma. 3. CHALLENGING MELANOCYTIC NEOPLASMS:
SPITZOID MELANOMA VERSUS SPITZ NEVUS. 4. Melanoma genomics: Techniques and implications for therapy. 5. Ras signaling in melanoma development and prevention. 6. Targeting BRAF activity as a novel paradigm for melanoma therapy. 7. Therapeutic targeting of the melanoma stem cell population. 8. Pigmentation pathways and Microphtalmia-Associated Transcription Factor as new targets in melanoma. 9. Understanding interferon: Translating biologic advances into clinical progress. 10. Interferon and autoimmunity. 11. New approaches for optimizing melanoma vaccines. 12. Adoptive T cell immunotherapy. 13. Procurement of human melanoma specimens for translational research: Practical and legal considerations. Glossary of clinical and scientific terms.